[Generation of a trans-complementable defective recombinant provirus and loading a transgene].
This work was aimed at generating a novel system for gene transfer to tumor cell, combining the advantages of non-viral gene transfer methods with those of transfer by recombinant retroviruses. We replaced the env gene of an infectious Moloney murine leukemia provirus with the gene coding for the thymidine kinase of Herpes Simplex Virus 1 (HSV1-TK). The sole transfection of this construction allows the production of viral particles, and the encapsidation of a viral genome carrying transgene. We show that this gene is expressed at a level sufficient for conferring sensitivity to ganciclovir, a nucleoside analog that is metabolised in a toxic compound by HSV1-TK. We also show that the complementation of this recombinant defective provirus with a gene coding for a retroviral envelope, either expressed constitutively by the transduced cell, or by co-transfection, leads to the formation of infectious viral particles capable of transducing HSV1-TK into tumor cells.
Noguiez-Hellin
P
P
Génopoïétic, Paris, France.
Robert-Le Meur
M
M
Laune
S
S
Salzmann
J L
JL
Klatzmann
D
D
D000998:Antiviral Agents / Q000494:pharmacology; D015774:Ganciclovir / Q000494:pharmacology; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D018259:Herpesvirus 1, Human / Q000235:genetics; D066298:In Vitro Techniques; D008979:Moloney murine leukemia virus / Q000235:genetics; D011533:Proviruses / Q000235:genetics*; D011995:Recombination, Genetic; D013937:Thymidine Kinase / Q000187:drug effects / Q000235:genetics; D019076:Transgenes
D000998:Antiviral Agents; D013937:Thymidine Kinase; D015774:Ganciclovir
Génération d'un provirus recombinant défectif complémentable en trans et véhiculant un transgène.